-
The surge of Covid-19 infections turned somewhat downward, but the continuous increase in severely ill patients is increasing burdens on the nation’s healthcare system, officials said.According to the Korea Disease Control and Prevention Agency (KDCA), new virus cases fell for the second straight da
Policy
Lee Han-soo
2022.08.12 19:01
-
Long-term care insurance reserves will dry out in 2026 and create a deficit of 76.7 trillion won ($58.9 billion) in 2070, a lawmaker said Friday, calling for the government to expand its financial support.Rep. Lee Jong-sung of the ruling People Power Party made a claim based on the long-term analysi
Policy
Kwak Sung-sun
2022.08.12 18:59
-
Death rate increases by up to a quarter among septic shock patients with sarcopenia, Severance Hospital said Friday.Infectious disease Professors Ku Nam-su and Kim Jung-ho announced that the mortality rate of septic shock patients with sarcopenia increased by up to 26.5 percent.There have been consi
Hospital
Kim Kee-won
2022.08.12 16:19
-
Voronoi said Friday that its next-generation non-small cell lung cancer (NSCLC) drug candidate, VRN11, has been selected as a new non-clinical support project by the Korea Drug Development Fund (KDDF).Voronoi will receive 1.2 billion won ($920,000) in full-time research and development expenses for
Pharma
Marianne Chang
2022.08.12 15:45
-
A Korean researcher said he identified the relationship between plasma glucose levels and radiotherapy's effect on cancer treatment.Professor Kong Moon-kyu of radiation oncology at Kyung Hee University Medical Center said his research team recently published a study, concluding that survival rates o
Hospital
Kim Eun-young
2022.08.12 15:45
-
A Korean medical group’s investigation revealed that the Covid-19 vaccination could have affected the onset of deep vein thrombosis (DVT) or cerebral venous sinus thrombosis (CVST). In addition, the group said that menstrual irregularities and abnormal uterine bleeding (AUB) were related to the Covi
Hospital
Koh Jung Min
2022.08.12 15:03
-
KAIST said Friday its researchers have succeeded in developing a new anticancer treatment using artificial intelligence-based virtual drug-screening technology. The signaling protein, known as mTOR, is excessively active in many cancer cells and plays a key role in various diseases, such as diabetes
Device/ICT
Marianne Chang
2022.08.12 14:00
-
Biosensor company i-SENS signed a memorandum of understanding with Meraki Place, a digital healthcare provider, to develop a chronic disease management service on Wednesday.Meraki Place runs a non-face-to-face medical treatment platform, My Doctor, and provides a one-stop service from treatment and
Bio
Kim Kee-won
2022.08.12 13:59
-
Menarini’s elacestrant, an oral selective estrogen receptor downregulator (SERD), is expected to obtain U.S. FDA approval in February, initiating competition against fulvestrant (brand name: Faslodex), a leading blockbuster drug in the breast cancer treatment market.On Thursday, the FDA announced th
Pharma
Kim Yun-mi
2022.08.12 12:02
-
Korea’s new Covid-19 cases fell Thursday after reaching a four-month record high the previous day. Still, new deaths and severe cases climbed to a three-month high amid the spread of highly contagious Omicron subvariants.The country added 137,241 new Covid-19 infections, bringing the total caseload
Policy
Lee Han-soo
2022.08.11 17:16
-
EOFlow said Thursday that A. Menarini Diagnostics would officially launch its tubeless, wearable, and disposable insulin pump in Europe under the diabetes care brand of “GlucoMen Day PUMP” on Sept. 1.EOPatch is one of only two fully disposable, wearable insulin pump solutions commercially available
Device/ICT
Marianne Chang
2022.08.11 17:02
-
The medical staff of Korea University Ansan Hospital (KUAH) provided medical assistance to ethnic Koreans who had evacuated to their fatherland because of Russia’s war in Ukraine.About 30 medical workers offered medical services at the foreign residents’ support center in Ansan, Gyeonggi Province, f
Hospital
Kim Kee-won
2022.08.11 17:02
-
Ilias Biologics said Thursday that its project to research and develop a treatment for inflammatory bowel disease (IBD) has been selected as the second national drug development project this year.The company added that it has also signed a final agreement.The national drug development project is an
Pharma
Marianne Chang
2022.08.11 15:53
-
International and Korean health experts will gather in Seoul this month to find ways to enhance the quality of data-driven healthcare, the health insurance review agency said.The Health Insurance Review and Assessment Service (HIRA) said it would host the “2022 International Symposium” to discuss ho
Policy
Kim Eun-young
2022.08.11 15:00
-
Local researchers have developed and proved the accuracy of a technology that can decipher the eyelid’s meibomian gland image using artificial intelligence.In the past, ophthalmologists measured meiboscore in degrees, a subjective reading method that lacks accuracy and reproducibility.Breaking away
Bio
Kim Kee-won
2022.08.11 14:56
-
Some people and organizations are better at turning crises into opportunities than others. Myongji Hospital in Goyang, a bed town north of Seoul, is one of them, cementing its position amid the Covid-19 pandemic with swift and well-prepared responses to the public health crisis.It is now offering th
Special
Marianne Chang
2022.08.11 14:56
-
Korean researchers said they confirmed a new therapeutic drug monitoring strategy to improve the treatment outcome in pediatric Crohn’s disease, a type of inflammatory bowel disease.On Thursday, a research team of Professors Kim Mi-jin and Choe Yon-ho of pediatrics at Samsung Medical Center said the
Hospital
Kim Eun-young
2022.08.11 14:53
-
Hanall Biopharma, a subsidiary of Daewoong Pharmaceutical, said it expanded the lineup of Biotop, over-the-counter probiotics.On Wednesday, Hanall Biopharma said it released Biotop Forte Cap. and Biotop Dual Cap.The existing Biotop series include Biotop D, a combination of lactic acid, butyric acid,
Pharma
Kim Chan-hyuk
2022.08.11 12:51
-
Amgen’s acute lymphoblastic leukemia (ALL) treatment Blincyto (ingredient: blinatumomab) passed the reimbursement review about two years after expanding indication to treat minimal residual disease (MRD) in patients with B-cell precursor ALL.In contrast, Amgen’s Xgeva (desonumab), which prevents ske
Policy
Kim Yun-mi
2022.08.11 12:23
-
Professor Song Kyoung-ho of the Department of Infectious Disease at Seoul National University Bundang Hospital has been appointed an editor of Scientific Reports, an international academic journal.Scientific Reports is an online, open-access journal published by the Nature Publishing Group and a sis
Hospital
Kim Kee-won
2022.08.11 12:22
